XML 24 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
Feb. 19, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39781    
Entity Registrant Name AbCellera Biologics Inc.    
Entity Incorporation, State or Country Code A1    
Entity Address, Address Line One 150 W 4th Avenue    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Postal Zip Code V5Y 1G6    
City Area Code 604    
Local Phone Number 559-9005    
Title of 12(b) Security Common shares, no par value per share    
Trading Symbol ABCL    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 789,227,743
Entity Common Stock, Shares Outstanding   303,160,487  
Documents Incorporated by Reference
The registrant’s definitive proxy statement relating to the annual meeting of shareholders will be filed with the Securities and Exchange Commission within 120 days after the close of the registrant’s fiscal year ended December 31, 2025 and is incorporated by reference in Part III to the extent described herein.
    
Entity Central Index Key 0001703057    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false